References

EMA (European Medicines Agency). 2010. The European Medicines Agency Road Map to 2015: The Agency’s Contribution to Science, Medicines, Health, Draft for Public Consultation. London: EMA.

FDA (Food and Drug Administration). 2010. Advancing Regulatory Science for Public Health. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm228131.htm (accessed November 28, 2011).

FDA. 2011. Advancing Regulatory Science at FDA: A Strategic Plan. http://www.fda.gov/regulatoryscience (accessed November 28, 2011).

FDA Science Board. 2007. FDA Science and Mission at Risk. Rockville, MD: Report of the Subcommittee on Science and Technology.

Hirsch, G. 2011. NEWDIGS: New Drug Development ParadIGmS: Applying MIT systems expertise to transform healthcare innovation. Presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 21, Washington, DC.

IOM (Institute of Medicine). 2011. Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary. Washington, DC: The National Academies Press.

Mollet, A. 2011. Education and Training of a Regulatory Science Workforce—European Initiatives. Presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 20, Washington, DC.

Seyfert-Margolis, V. 2011. Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: An Institute of Medicine Workshop. Speaker presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 20, Washington, DC.

Ukwu, H. 2011. Regulatory Science in Therapeutics Development. Presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 20, Washington, DC.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 65
References EMA (European Medicines Agency). 2010. The European Medicines Agency Road Map to 2015: The Agency’s Contribution to Science, Medicines, Health, Draft for Public Consultation. London: EMA. FDA (Food and Drug Administration). 2010. Advancing Regulatory Science for Public Health. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm228131. htm (accessed November 28, 2011). FDA. 2011. Advancing Regulatory Science at FDA: A Strategic Plan. http://www.fda.gov/ regulatoryscience (accessed November 28, 2011). FDA Science Board. 2007. FDA Science and Mission at Risk. Rockville, MD: Report of the Subcommittee on Science and Technology. Hirsch, G. 2011. NEWDIGS: New Drug Development ParadIGmS: Applying MIT systems exper - tise to transform healthcare innovation. Presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 21, Washington, DC. IOM (Institute of Medicine). 2011. Building a National Framework for the Establishment of Regu- latory Science for Drug Development: Workshop Summary. Washington, DC: The National Academies Press. Mollet, A. 2011. Education and Training of a Regulatory Science Workforce—European Initiatives . Presentation at IOM workshop on Strengthening a Workforce for Innovative Regula - tory Science in Therapeutics Development, September 20, Washington, DC. Seyfert-Margolis, V. 2011. Strengthening a Workforce for Innovative Regulatory Science in Thera- peutics Development: An Institute of Medicine Workshop. Speaker presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Thera - peutics Development, September 20, Washington, DC. Ukwu, H. 2011. Regulatory Science in Therapeutics Development. Presentation at IOM work- shop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 20, Washington, DC. 65

OCR for page 65